Your browser doesn't support javascript.
loading
Genomic signatures define three subtypes of EGFR-mutant stage II-III non-small-cell lung cancer with distinct adjuvant therapy outcomes.
Liu, Si-Yang; Bao, Hua; Wang, Qun; Mao, Wei-Min; Chen, Yedan; Tong, Xiaoling; Xu, Song-Tao; Wu, Lin; Wei, Yu-Cheng; Liu, Yong-Yu; Chen, Chun; Cheng, Ying; Yin, Rong; Yang, Fan; Ren, Sheng-Xiang; Li, Xiao-Fei; Li, Jian; Huang, Cheng; Liu, Zhi-Dong; Xu, Shun; Chen, Ke-Neng; Xu, Shi-Dong; Liu, Lun-Xu; Yu, Ping; Wang, Bu-Hai; Ma, Hai-Tao; Yan, Hong-Hong; Dong, Song; Zhang, Xu-Chao; Su, Jian; Yang, Jin-Ji; Yang, Xue-Ning; Zhou, Qing; Wu, Xue; Shao, Yang; Zhong, Wen-Zhao; Wu, Yi-Long.
Affiliation
  • Liu SY; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, and Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
  • Bao H; Nanjing Geneseeq Technology Inc., Nanjing, China.
  • Wang Q; Fudan University Affiliated Zhongshan Hospital, Shanghai, China.
  • Mao WM; Zhejiang Cancer Hospital, Hangzhou, China.
  • Chen Y; Nanjing Geneseeq Technology Inc., Nanjing, China.
  • Tong X; Nanjing Geneseeq Technology Inc., Nanjing, China.
  • Xu ST; Fudan University Affiliated Zhongshan Hospital, Shanghai, China.
  • Wu L; Hunan Cancer Hospital, Changsha, China.
  • Wei YC; The Affiliated Hospital of Medical College Qingdao University, Qingdao, China.
  • Liu YY; Shenyang Chest Hospital, Shenyang, China.
  • Chen C; Fujian Medical University Union Hospital, Fuzhou, China.
  • Cheng Y; Jilin Provincial Tumor Hospital, Changchun, China.
  • Yin R; Jiangsu Cancer Hospital, Nanjing, China.
  • Yang F; The People's Hospital of Peking University, Beijing, China.
  • Ren SX; Shanghai Pulmonary Hospital, Shanghai, China.
  • Li XF; Tangdu Hospital, Xi'an, China.
  • Li J; Peking University First Hospital, Beijing, China.
  • Huang C; Fujian Cancer Hospital, Fuzhou, China.
  • Liu ZD; Beijing Chest Hospital, Beijing, China.
  • Xu S; The First Hospital of China Medical University, Shenyang, China.
  • Chen KN; Beijing Cancer Hospital, Beijing, China.
  • Xu SD; Harbin Medical University Cancer Hospital, Harbin, China.
  • Liu LX; West China Hospital of Sichuan University, Chengdu, China.
  • Yu P; Sichuan Cancer Hospital, Chengdu, China.
  • Wang BH; The Northern Jiangsu People's Hospital, Yangzhou, China.
  • Ma HT; The First Affiliated Hospital of Suzhou University, Suzhou, China.
  • Yan HH; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, and Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
  • Dong S; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, and Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
  • Zhang XC; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, and Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
  • Su J; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, and Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
  • Yang JJ; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, and Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
  • Yang XN; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, and Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
  • Zhou Q; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, and Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
  • Wu X; Nanjing Geneseeq Technology Inc., Nanjing, China.
  • Shao Y; Nanjing Geneseeq Technology Inc., Nanjing, China.
  • Zhong WZ; School of Public Health, Nanjing Medical University, Nanjing, China.
  • Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, and Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China. syzhongwenzhao@scut.edu.cn.
Nat Commun ; 12(1): 6450, 2021 11 08.
Article in En | MEDLINE | ID: mdl-34750392
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Humans Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2021 Document type: Article Affiliation country: China Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Humans Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2021 Document type: Article Affiliation country: China Country of publication: Reino Unido